Acyclovir
NDC Package 61919-331-30
Package Information
Acyclovir is used to treat infections caused by certain types of viruses. Marketed by Direct_rx, this product is identified by NDC 61919-331 and is authorized under FDA application ANDA075677.
Identification & Billing
- RxCUI: 197310 - acyclovir 200 MG Oral Capsule
- RxCUI: 197310 - acycycloguanosine 200 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 61919 - Direct_rx
- 61919-331 - Acyclovir
- 61919-331-30 - 30 CAPSULE in 1 BOTTLE
- 61919-331 - Acyclovir
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 61919-331-30 identifies a specific commercial package of 30 capsule in 1 bottle of Acyclovir, labeled by Direct_rx. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Direct_rx on July 24, 2019. The current certification is valid through December 31, 2022.
What are the primary indications for this medication?
Acyclovir is used to treat infections caused by certain types of viruses. It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections.
How is this Direct_rx product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 61919033130. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.